Gabelli & Co Investment Advisers’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,990	Closed	-$1.29M	–	247
2020 Q2	$1.29M	Hold	5,990	–	–	0.29%	74
2020 Q1	$1.26M	Sell	5,990 -3,735	-38%	-$783K	0.19%	81
2019 Q4	$2.04M	Hold	9,725	–	–	0.24%	74
2019 Q3	$2.01M	Hold	9,725	–	–	0.23%	72
2019 Q2	$1.99M	Hold	9,725	–	–	0.21%	78
2019 Q1	$1.96M	Buy	+9,725	New	+$1.95M	0.25%	68

Other funds holding RVPH

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Gabelli & Co Investment Advisers's RVPH Position: Q3 2020 in Review

Gabelli & Co Investment Advisers sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2020, closing a stake of 5,990 shares — an estimated $1.29M sold.

Gabelli & Co Investment Advisers first reported a position in RVPH in Q1 2019 and held it in 6 quarters. The position peaked at $2.04M in Q4 2019. 13 funds tracked by Wall St. Rank hold RVPH as of Q3 2020.

Gabelli & Co Investment Advisers reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 5,990 REVIVA PHARMA HLDGS INC shares in Q3 2020, an estimated $1.29M.
Gabelli & Co Investment Advisers first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 6 quarters.
Gabelli & Co Investment Advisers's REVIVA PHARMA HLDGS INC position peaked at $2.04M in Q4 2019.
13 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2020, filed 6 Nov 2020.